Senseonics Holdings Inc SENS:NYSE American

Last Price$2.85AMEX Previous Close - Last Trade as of 8:00PM ET 12/01/21

Today's Change-0.29(9.24%)
Bid (Size)$2.93 (12)
Ask (Size)$2.95 (2)
Day Low / High$2.85 - 3.16
Volume18.7 K
 

View Electronic Components IndustryPeer Comparison as of 12/01/2021

 

Senseonics Holdings Inc ( NYSE MKT LLC )

Price: $2.85
Change: -0.29 (9.24%)
Volume: 18.7 K
8:00PM ET 12/01/2021
 
 

TTM Technologies Inc ( NASDAQ )

Price: $13.81
Change: +0.03 (0.22%)
Volume: 1.2 M
4:00PM ET 12/01/2021
 
 

MicroVision Inc ( NASDAQ )

Price: $6.66
Change: -0.42 (5.93%)
Volume: 748.00
4:00PM ET 12/01/2021
 
 

CTS Corp ( NYSE )

Price: $35.22
Change: +0.38 (1.09%)
Volume: 270.9 K
7:00PM ET 12/01/2021
 
 

Methode Electronics Inc ( NYSE )

Price: $44.82
Change: +0.35 (0.79%)
Volume: 166.7 K
7:00PM ET 12/01/2021
 

Read more news Recent News

Insider Sell: Senseonics Holdings
12:19PM ET 11/18/2021 MT Newswires

Mukul Jain, Chief Operating Officer, on November 15, 2021, sold 100,000 shares in Senseonics Holdings (SENS) for $370,000. Following the Form 4 filing with...

-- Earnings Flash (SENS) SENSEONICS HOLDINGS Posts Q3 Revenue $3.5M, vs. Street Est of $3.57M
4:28PM ET 11/09/2021 MT Newswires

...

Senseonics' Glucose Monitoring System to be Offered to University Hospitals Accountable Care Organization's Medicare Members in Cleveland, Ohio
4:44AM ET 9/14/2021 MT Newswires

Senseonics (SENS) and its commercialization partner, Ascensia Diabetes Care, said on Monday that the Eversense continuous glucose monitoring system will be...

--HC Wainwright Starts Senseonics Holdings at Buy With $6 Price Target
7:00AM ET 8/19/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Company Profile

Business DescriptionSenseonics Holdings, Inc. engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application. The company was founded on June 26, 2014 and is headquartered in Germantown, MD. View company web site for more details
Address20451 Seneca Meadows Parkway
Germantown, Maryland 20876-7005
Phone+1.301.515.7260
Number of Employees192
Recent SEC Filing11/18/20214
President, Chief Executive Officer & DirectorTimothy T. Goodnow
Chief Operating OfficerMukul Jain
Secretary, Chief Financial & Accounting OfficerNick B Tressler
Director & Chief Medical OfficerFrancine R. Kaufman

Company Highlights

Price Open$3.15
Previous Close$2.85
52 Week Range$0.36 - 5.56
Market Capitalization$1.3 B
Shares Outstanding446.0 M
SectorElectronic Technology
IndustryElectronic Components
Next Earnings Announcement03/03/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.56
Beta vs. S&P 500N/A
Revenue$18.9 M
Net Profit Margin-3,604.91%
Return on Equity215.58%

Analyst Ratings as of 10/28/2021

Buy
3
Overweight
0
Hold
2
Underweight
0
Sell
2
Consensus RecommendationConsensus Icon
Powered by Factset